These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
252 related items for PubMed ID: 17190768
1. Changes over a 20-year period in the clinical presentation of primary sclerosing cholangitis in Sweden. Bergquist A, Said K, Broomé U. Scand J Gastroenterol; 2007 Jan; 42(1):88-93. PubMed ID: 17190768 [Abstract] [Full Text] [Related]
2. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Bergquist A, Glaumann H, Persson B, Broomé U. Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625 [Abstract] [Full Text] [Related]
3. Magnetic resonance cholangiopancreatography in the diagnosis of primary sclerosing cholangitis. Weber C, Kuhlencordt R, Grotelueschen R, Wedegaertner U, Ang TL, Adam G, Soehendra N, Seitz U. Endoscopy; 2008 Sep; 40(9):739-45. PubMed ID: 18698533 [Abstract] [Full Text] [Related]
4. Cholangiocarcinoma in young individuals with and without primary sclerosing cholangitis. Björnsson E, Angulo P. Am J Gastroenterol; 2007 Aug; 102(8):1677-82. PubMed ID: 17433022 [Abstract] [Full Text] [Related]
5. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study. Chalasani N, Baluyut A, Ismail A, Zaman A, Sood G, Ghalib R, McCashland TM, Reddy KR, Zervos X, Anbari MA, Hoen H. Hepatology; 2000 Jan; 31(1):7-11. PubMed ID: 10613720 [Abstract] [Full Text] [Related]
6. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients? Bayraktar Y, Arslan S, Saglam F, Uzunalimoglu B, Kayhan B. Hepatogastroenterology; 1998 Jan; 45(24):2064-72. PubMed ID: 9951867 [Abstract] [Full Text] [Related]
7. High lifetime risk of cancer in primary sclerosing cholangitis. Claessen MM, Vleggaar FP, Tytgat KM, Siersema PD, van Buuren HR. J Hepatol; 2009 Jan; 50(1):158-64. PubMed ID: 19012991 [Abstract] [Full Text] [Related]
8. Immune-mediated diseases in primary sclerosing cholangitis. Lamberts LE, Janse M, Haagsma EB, van den Berg AP, Weersma RK. Dig Liver Dis; 2011 Oct; 43(10):802-6. PubMed ID: 21700515 [Abstract] [Full Text] [Related]
9. [MRCP in primary sclerosing cholangitis]. Weber C, Krupski G, Lorenzen J, Grotelüschen R, Seitz U, Rogiers X, Adam G. Rofo; 2003 Feb; 175(2):203-10. PubMed ID: 12584620 [Abstract] [Full Text] [Related]
10. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Tischendorf JJ, Krüger M, Trautwein C, Duckstein N, Schneider A, Manns MP, Meier PN. Endoscopy; 2006 Jul; 38(7):665-9. PubMed ID: 16673310 [Abstract] [Full Text] [Related]
11. Primary sclerosing cholangitis can present with acute liver failure: Report of two cases. Bergquist A, Glaumann H, Lindberg B, Broomé U. J Hepatol; 2006 May; 44(5):1005-8. PubMed ID: 16551483 [Abstract] [Full Text] [Related]
12. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence. Lewis JT, Talwalkar JA, Rosen CB, Smyrk TC, Abraham SC. Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079 [Abstract] [Full Text] [Related]
13. Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis. Ngu JH, Gearry RB, Wright AJ, Stedman CA. Clin Gastroenterol Hepatol; 2011 Dec; 9(12):1092-7; quiz e135. PubMed ID: 21893134 [Abstract] [Full Text] [Related]
14. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease. Brackmann S, Andersen SN, Aamodt G, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH. Scand J Gastroenterol; 2009 Dec; 44(1):46-55. PubMed ID: 18609187 [Abstract] [Full Text] [Related]
15. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Vera A, Gunson BK, Ussatoff V, Nightingale P, Candinas D, Radley S, Mayer A, Buckels JA, McMaster P, Neuberger J, Mirza DF. Transplantation; 2003 Jun 27; 75(12):1983-8. PubMed ID: 12829898 [Abstract] [Full Text] [Related]
17. The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis. Kaplan GG, Laupland KB, Butzner D, Urbanski SJ, Lee SS. Am J Gastroenterol; 2007 May 27; 102(5):1042-9. PubMed ID: 17313496 [Abstract] [Full Text] [Related]
18. Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis. Tischendorf JJ, Meier PN, Strassburg CP, Klempnauer J, Hecker H, Manns MP, Krüger M. Scand J Gastroenterol; 2006 Oct 27; 41(10):1227-34. PubMed ID: 16990210 [Abstract] [Full Text] [Related]
19. The challenges in primary sclerosing cholangitis--aetiopathogenesis, autoimmunity, management and malignancy. Weismüller TJ, Wedemeyer J, Kubicka S, Strassburg CP, Manns MP. J Hepatol; 2008 Oct 27; 48 Suppl 1():S38-57. PubMed ID: 18304683 [Abstract] [Full Text] [Related]